Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
sortieren
Medicine and Dentistry
Adenoma
48%
Adverse Event
80%
Antiviral Therapy
32%
Artificial Intelligence
76%
Bleeding
75%
Charlson Comorbidity Index
28%
Cholecystectomy
25%
Chronic Hepatitis C
26%
Chronic Liver Disease
28%
Cohort Analysis
27%
Colon
28%
Colonoscopy
90%
Colorectal Carcinoma
29%
COVID-19
25%
Decompensated Liver Cirrhosis
31%
Diseases
59%
Endoscopic Retrograde Cholangiopancreatography
76%
Endoscopic Ultrasound
51%
Endoscopy
58%
Fibrosis
41%
Fine-Needle Aspiration
42%
Gastrointestinal Endoscopy
36%
Health Care
51%
Hepatitis C
38%
Hepatitis Delta Virus
25%
Hepatocellular Carcinoma
83%
Hepatology
51%
Interferon
27%
Interventional Radiology
25%
Lenvatinib
51%
Liver Cirrhosis
92%
Liver Disease
34%
Liver Transplantation
42%
Metabolic Dysfunction-Associated Steatotic Liver Disease
28%
Nonalcoholic Fatty Liver
25%
Odds Ratio
27%
Pancreas Tumor
25%
Pancreatitis
28%
Polyp
44%
Portal Hypertension
61%
Prevalence
51%
Prospective Study
76%
Puncture
34%
Recurrent Disease
34%
Ribavirin
57%
Ulcer
40%
Upper Gastrointestinal Bleeding
51%
Viral Clearance
25%
Virus RNA
28%
Zenker's Diverticulum
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoma
19%
Adverse Event
42%
Alpha2a Interferon
25%
Antiviral Drug
17%
Antiviral Therapy
28%
Antivirus Agent
22%
Atezolizumab
25%
Bevacizumab
25%
Bulevirtide
27%
Cancer Mortality
25%
Cardiovascular Disease
25%
Cholestasis
12%
Chronic Hepatitis C
68%
Cohort Study
51%
Colorectal Carcinoma
51%
Coronary Artery Calcification
18%
Decompensated Liver Cirrhosis
31%
Delta Agent Hepatitis
25%
Diseases
43%
Fatty Liver
21%
Felty's Syndrome
25%
Fibrosis
40%
Glecaprevir
25%
Hepatitis C
40%
Hepatitis C Virus
53%
Hepatitis Delta Virus
25%
Infection
26%
Interferon
27%
Lenvatinib
51%
Liver Cell Carcinoma
88%
Liver Cirrhosis
100%
Liver Disease
39%
Nonalcoholic Fatty Liver
51%
Ombitasvir
12%
Pancreatitis
34%
Pandemic
25%
Paritaprevir
12%
Peginterferon Alpha
25%
Pharmacokinetics
25%
Pibrentasvir
25%
Prevalence
53%
Proton Pump Inhibitor
25%
Recurrent Disease
25%
Reducing Agent
25%
Ribavirin
64%
Selenoprotein P
25%
Sofosbuvir
17%
Viral Clearance
54%
Virus RNA
54%
Von Willebrand Factor
25%